Warensjö Eva, Risérus Ulf, Gustafsson Inga-Britt, Mohsen Rawya, Cederholm Tommy, Vessby Bengt
Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Nutr Metab Cardiovasc Dis. 2008 Dec;18(10):683-90. doi: 10.1016/j.numecd.2007.11.002. Epub 2008 Mar 25.
Direct measurement of desaturase activities are difficult to obtain in humans. Consequently, surrogate measures of desaturase activity (estimated desaturase activities) have been frequently used in observational studies, and estimated Delta(9)- (or stearoyl-CoA-desaturase (SCD)), Delta(6)- and Delta(5)-desaturase activities have been associated with cardiometabolic disease. Data on how the markers of desaturase activities are modified by changes in dietary fat quality are lacking and therefore warrant examination.
In a two-period (three weeks) strictly controlled cross-over study, 20 subjects (six women and 14 men) consumed a diet high in saturated fat (SAT-diet) and a rapeseed oil diet (RO-diet), rich in oleic acid (OA), linoleic acid (LA) and alpha-linolenic acid (ALA). Estimated desaturase activities were calculated as precursor to product FA ratios in serum cholesteryl esters and phospholipids. The estimated SCD [16:1 n-7/16:0] and Delta(6)-desaturase [20:3 n-6/18:2 n-6] was significantly higher while Delta(5)-desaturase [20:4 n-6/20:3 n-6] was significantly lower in the SAT-diet (P<0.001 for all), compared to the RO-diet. The serum proportions of palmitic, stearic, palmitoleic and dihomo-gamma-linolenic acids were significantly higher in the SAT-diet while the proportions of LA and ALA were significantly higher in the RO-diet.
This is the first study to demonstrate that surrogate measures of desaturase activities change as a consequence of an alteration in dietary fat quality. Both the [16:1/16:0]-ratio and 16:1 seem to reflect changes in saturated fat intake and may be useful markers of saturated fat intake in Western countries.
在人体中难以直接测量去饱和酶活性。因此,在观察性研究中经常使用去饱和酶活性的替代指标(估计的去饱和酶活性),并且估计的Δ9-(或硬脂酰辅酶A去饱和酶(SCD))、Δ6-和Δ5-去饱和酶活性已与心脏代谢疾病相关。关于去饱和酶活性标志物如何因膳食脂肪质量变化而改变的数据缺乏,因此值得研究。
在一项为期两期(三周)的严格对照交叉研究中,20名受试者(6名女性和14名男性)食用了高饱和脂肪饮食(SAT饮食)和富含油酸(OA)、亚油酸(LA)和α-亚麻酸(ALA)的菜籽油饮食(RO饮食)。估计的去饱和酶活性通过血清胆固醇酯和磷脂中前体与产物脂肪酸的比率来计算。与RO饮食相比,SAT饮食中估计的SCD [16:1 n-7/16:0]和Δ6-去饱和酶[20:3 n-6/18:2 n-6]显著更高,而Δ5-去饱和酶[20:4 n-6/20:3 n-6]显著更低(所有P<0.001)。SAT饮食中棕榈酸、硬脂酸、棕榈油酸和二高-γ-亚麻酸的血清比例显著更高,而RO饮食中LA和ALA的比例显著更高。
这是第一项证明去饱和酶活性的替代指标会因膳食脂肪质量改变而变化的研究。[16:1/16:0]比率和16:1似乎都反映了饱和脂肪摄入量的变化,可能是西方国家饱和脂肪摄入量的有用标志物。